Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
R

Rapid Dose Therapeutics Corp
CNSX:DOSE

Watchlist Manager
Rapid Dose Therapeutics Corp
CNSX:DOSE
Watchlist
Price: 0.155 CAD 14.81% Market Closed
Market Cap: CA$21m
Write Note Create Alert Ask AI

Profitability Summary

Rapid Dose Therapeutics Corp's profitability score is 41/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

41/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

41/100
Profitability
Score
41/100
Profitability
Score

Margins

Earnings Waterfall
Rapid Dose Therapeutics Corp

Margins Comparison
Rapid Dose Therapeutics Corp Competitors

Country Company Market Cap Gross
Margin 		Operating
Margin 		Net
Margin
CA
Rapid Dose Therapeutics Corp
CNSX:DOSE
20.6m CAD
Loading...
Loading...
Loading...
US
Becton Dickinson and Co
NYSE:BDX
50.1B USD
Loading...
Loading...
Loading...
US
Dexcom Inc
NASDAQ:DXCM
27.3B USD
Loading...
Loading...
Loading...
US
Zimmer Biomet Holdings Inc
NYSE:ZBH
19.1B USD
Loading...
Loading...
Loading...
JP
Terumo Corp
TSE:4543
2.9T JPY
Loading...
Loading...
Loading...
US
West Pharmaceutical Services Inc
NYSE:WST
18B USD
Loading...
Loading...
Loading...
US
ABIOMED Inc
LSE:0H7S
17.2B USD
Loading...
Loading...
Loading...
US
Insulet Corp
NASDAQ:PODD
17.1B USD
Loading...
Loading...
Loading...
US
Shockwave Medical Inc
F:36M
11.3B EUR
Loading...
Loading...
Loading...
US
Penumbra Inc
NYSE:PEN
13.3B USD
Loading...
Loading...
Loading...
NZ
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
21.1B NZD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Rapid Dose Therapeutics Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CA
Rapid Dose Therapeutics Corp
CNSX:DOSE
20.6m CAD
Loading...
Loading...
Loading...
Loading...
US
Becton Dickinson and Co
NYSE:BDX
50.1B USD
Loading...
Loading...
Loading...
Loading...
US
Dexcom Inc
NASDAQ:DXCM
27.3B USD
Loading...
Loading...
Loading...
Loading...
US
Zimmer Biomet Holdings Inc
NYSE:ZBH
19.1B USD
Loading...
Loading...
Loading...
Loading...
JP
Terumo Corp
TSE:4543
2.9T JPY
Loading...
Loading...
Loading...
Loading...
US
West Pharmaceutical Services Inc
NYSE:WST
18B USD
Loading...
Loading...
Loading...
Loading...
US
ABIOMED Inc
LSE:0H7S
17.2B USD
Loading...
Loading...
Loading...
Loading...
US
Insulet Corp
NASDAQ:PODD
17.1B USD
Loading...
Loading...
Loading...
Loading...
US
Shockwave Medical Inc
F:36M
11.3B EUR
Loading...
Loading...
Loading...
Loading...
US
Penumbra Inc
NYSE:PEN
13.3B USD
Loading...
Loading...
Loading...
Loading...
NZ
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
21.1B NZD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Rapid Dose Therapeutics Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

See Also

Summary
DOSE intrinsic value, competitors valuation, and company profile.
DCF Valuation
DOSE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DOSE stock valuation using valuation multiples.
Wall Street Estimates
DOSE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DOSE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 318,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.